Teva Offers Update On Operations In Israel :: Generics Bulletin
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Israel's Teva agrees to pay $126 mln to US hospitals over opioids
Teva Pharmaceuticals, Ltd., Israel - AMR Industry Alliance
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Accused of Manipulating Patent to Monopolize Inhaler Market
Teva Pharmaceuticals Office Photos
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Israel's Teva Halts Testing Alternative Use for Migraine Drug - Business - Haaretz.com
Teva May Need to Pay Up to Lure a CEO Able to Reverse Its Fortunes - WSJ
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
Teva May Need to Pay Up to Lure a CEO Able to Reverse Its Fortunes - WSJ
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. - Barron's
Teva Pharmaceuticals - Wikipedia
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY